Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pharma Worried By EMA’s Stricter Approach To New Active Substance Claims For Biologics
Jun 15 2023
•
By
Vibha Sharma
NAS status is important for companies to protect their drug from generic competition for several years • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography